Researchers Use the ProteOn™ XPR36 system to Study the Mechanisms Underlying Cancer, Alzheimer’s Disease, and Other Conditions

Product News   Sep 27, 2012

 
Researchers Use the ProteOn™ XPR36 system to Study the Mechanisms Underlying Cancer, Alzheimer’s Disease, and Other Conditions
FURTHER INFORMATION
 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE
 
 

Related Product News

Merck Expands End-to-End Biodevelopment Capability

Product News

Two new process development centers in the U.S. and China, in addition to its established center in France, will enhance Merck's end-to-end biodevelopment capabilities.

READ MORE

Fatty Acid Oxidation Kit

Product News

AMSBIO has introduced the MitoXpress® Xtra Fatty Acid Oxidation (FAO) kit to facilitate the convenient measurement of FAO-driven respiration.

READ MORE

Development of Nanoscale Vehicles for Drug Delivery

Product News

Postnova Analytics reports how the Department of Chemistry at University College London (UCL) is using an AF2000 Field Flow Fractionation System to assist them in their development of novel nanoscale vehicles for drug delivery.

READ MORE